Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:52:49.268Z.
Calculation as of: 2026-10-06T14:52:49.268Z.
Quote observation: 2026-10-06T14:49:47.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a391670e5a4a022aad0cee8204cefb21b4613c0a4e77d467850b61b24c11a6b7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Korsana Biosciences, Inc.
Market Cap
$144.02M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$143.39M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$147.08M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$146.71M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$147.97M
Operating Cash Flow Yield
N/A
TTM Avg
1.16%
3Y Avg
1.36%
5Y Avg
1.36%
Market Cap
$138.69M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$140.03M
Operating Cash Flow Yield
0.91%
TTM Avg
3.24%
3Y Avg
4.92%
5Y Avg
5.15%
Market Cap
$139.73M
Operating Cash Flow Yield
90.12%
TTM Avg
20.54%
3Y Avg
20.54%
5Y Avg
20.54%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korsana Biosciences, Inc. (KRSA) | $144.02M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $143.39M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $147.08M | N/A | N/A | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $146.71M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | N/A | 1.16% | 1.36% | 1.36% |
| Alpha Cognition Inc (ACOG)vs › | $138.69M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $140.03M | 0.91% | 3.24% | 4.92% | 5.15% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 90.12% | 20.54% | 20.54% | 20.54% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.65M | 1.02% | 0.36% | 0.36% | 0.36% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
